$ACA

Arcosa, Inc. (ACA): Entry into a Material Definitive Agreement

Arcosa, Inc. (ACA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 exh21mergeragreement.htm EX-2.1 Document EXHIBIT 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among CRH AMERICAS, INC., NEON MERGER SUB, INC. and ARCOSA, INC. dated as of June 21, 2026 TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS 1 Section 1.1. Defin

Original reporting
Published Jun 22, 2026, 11:21 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 22, 2026, 11:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$ACA
Bullish
medium confidence
Mentioned
$ACA
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ACABullishMed
01

Why it matters

This is a primary disclosure of a definitive merger agreement, which typically shifts the stock from standalone fundamentals to deal-spread dynamics (probability-weighted closing).

02

Market read

Definitive merger agreement disclosure is actionable for ACA deal-traders, but the excerpt lacks purchase price and key economic terms.

03

What to watch

Traders should watch for deal conditions, financing certainty, regulatory approvals, and any shareholder litigation/proxy timeline details that often drive spread and volatility after a definitive agreement 8-K.

Relevance 6/10Novelty 6/10Timing: as of the 8-K filing today (June 22, 2026) for the announced merger agreement

Background

Arcosa filed an 8-K indicating it entered a material definitive agreement for a merger, with CRH Americas as the parent and a merger sub as the acquiring vehicle.

Company-level read

Ticker impact

$ACABullishMedium confidence
Context

Arcosa entered a material definitive merger agreement, with its shares to be converted into the right to receive merger consideration.

Expected impact

Likely supportive for ACA on deal headlines, with volatility around deal terms, regulatory/closing conditions, and any competing bids.

Evidence & confidence

The filing is a primary-source 8-K entry into a merger plan; however, the excerpt does not include the purchase price or key deal economics, limiting precision on magnitude.

Market effects

Could modestly affect sentiment for construction materials/aggregates and related logistics supply chains if the deal signals consolidation appetite.

Limited from the excerpt; any impact would depend on CRH’s footprint and regulatory review scope.

Low from the excerpt; cross-border relevance depends on CRH Americas’ broader strategy and any international approvals.

Counterpoint

Without disclosed consideration/structure in the excerpt, the market may fade initial enthusiasm if terms are unattractive or if closing risk is high.

Key entities

  • Arcosa, Inc.

    Target company entering a material definitive merger agreement; its common stock will be converted into the right to receive merger consideration.

  • CRH Americas, Inc.

    Parent/acquirer in the merger agreement (as disclosed in the exhibit).

  • Neon Merger Sub, Inc.

    Wholly owned merger subsidiary of CRH Americas that will merge into Arcosa.

Related articles

$ACAMed

Arcosa, Inc. (ACA): Results of Operations and Financial Condition

Arcosa, Inc. (ACA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh991earningsrelease63020.htm EX-99.1 Document Exhibit 99.1 News Release FOR IMMEDIATE RELEASE Arcosa, Inc. Announces Second Quarter 2026 Results DALLAS, Texas - ARCOSA, Inc. - August 5, 2026: Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provid

$CRHHighAI 9/10

CRH to Buy Arcosa, Shares Skid

CRH said it will buy 100% of Arcosa in an all-cash deal for $150 per share, subject to Arcosa shareholder and regulatory approvals. The offer implies a 25% premium to Arcosa’s June 18 60-day VWAP. CRH values Arcosa at about $8.5B enterprise value (11.5x 2026E adj. EBITDA) and expects $175M annual synergies by year three.

$PLTRMed

Stocks Erase Early Gains as Alphabet and Software Companies Fall

US stocks gave back early gains as software and defense shares fell. Alphabet dropped over 6% after Google DeepMind VP Jumper said to be leaving for Anthropic. Defense names slid after Iran said it made “major progress” with the US on a peace deal. Rates: 10-year Treasury yield rose to 4.489% amid $211B in auctions. Semiconductors and AI stocks led gains; Palantir, Intuit, Oracle fell, while SOXX hit a record.

$CRHHighAI 9/10

CRH To Acquire Arcosa For $150/share, Arcosa Up In Pre-market

CRH plc agreed to acquire Arcosa, Inc. for $150 per share in cash, valuing Arcosa at about $8.5 billion and implying a 25% premium to its 60-day VWAP as of June 18, according to CRH. CRH expects $175 million in annual run-rate cost synergies by year three and accretion within 12 months after closing, targeted for Q1 2027.